Angela M. Cacace - 17 Jun 2026 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Reporting relationship: Chief Scientific Officer
Issuer ticker: ARVN
Reported as of: 17 Jun 2026
Net transaction value: -$19,565
SEC form: 4
Accepted by SEC: 18 Jun 2026, 16:06:53 UTC
Prior SEC filing: 13 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace

Key filing fact

Angela M. Cacace filed Form 4 for ARVINAS, INC. (ARVN) on 18 Jun 2026.

Key facts

This page summarizes Angela M. Cacace's Form 4 filing for ARVINAS, INC. (ARVN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Jun 2026, 16:06.

Change

Previous filing in this sequence was filed on 13 May 2026.
Current net transaction value: -$19,565.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002026306 Primary reporting owner

Cacace Angela M

Relationship: Chief Scientific Officer
Address: C/O ARVINAS, INC., 5 SCIENCE PARK, 395 WINCHESTER AVE., NEW HAVEN
Signature: /s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace
Signature date: 18 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARVN transaction

Common Stock

Sale

Transaction value: $19,565
Shares: -2,576
Change %: -1.4%
Price: $7.60
Shares after: 180,390
Date: 17 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs) granted on June 17, 2024 pursuant to a durable sale instruction. The sale does not represent a discretionary trade.